US FDA Launches Patient Engagement Advisory Committee For Devices
This article was originally published in SRA
Executive Summary
The US Food and Drug Administration is setting up a Patient Engagement Advisory Committee to help the agency incorporate the needs and experiences of patients into its regulatory decisions for medical devices and diagnostics1.